Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
315
-
Total 13F shares, excl. options
-
129M
-
Shares change
-
-15.1M
-
Total reported value, excl. options
-
$2.55B
-
Value change
-
-$263M
-
Put/Call ratio
-
1.03
-
Number of buys
-
116
-
Number of sells
-
-127
-
Price
-
$19.73
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2019
369 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2019.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 315 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 129M shares
.
Largest 10 shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (30.6M shares), PAULSON & CO. INC. (13.2M shares), Adelphi Capital LLP (8.96M shares), VANGUARD GROUP INC (5.98M shares), MACQUARIE GROUP LTD (5.11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.11M shares), BANK OF AMERICA CORP /DE/ (3.96M shares), NORTHERN TRUST CORP (3.75M shares), Mondrian Investment Partners LTD (3.64M shares), and Parametric Portfolio Associates LLC (3.5M shares).
This table shows the top 315 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.